Organofluorine compounds 1 are widely used in pharmaceutical 2 and agrochemical 3 industries as well as in medical diagnostics. 4 The foremost radionuclide in Positron Emission Tomography (PET) is fluorine-18 because of its half-life of 109.8 minutes, the strong C-F bonding and the usually high metabolic stability of organofluorines. 4 The optimal conditions for synthesis of organofluorines with the natural isotope fluorine-19 and those containing the radioactive isotope fluorine-18 are often fundamentally different. An important challenge in radiochemistry is to obtain 18 F-labelled organofluorine species in high radiochemical conversion (RCC) and at high molar activity within the lifetime of fluorine-18. Traditionally, high molar activity could only be achieved by nucleophilic 18 F-fluorination reactions. (Fig. 1c) .
Our fluorine-19 experiments have shown that the synthesis of 1 from commonly used benziodoxole precursors, such as OH, OAc and halogenide derivatives requires relatively long reaction times (0.5-4 h). Therefore, the highly reactive (yet bench-stable) tosyl derivative 2 12c was selected as precursor for the radiosynthesis.
Reagent 1 partially or completely decomposes under chromatography due to the high affinity of the iodine bound fluorine to Si, Al and alkali metal ions. Indeed, over 95% of [ 18 F]1 was lost, when we attempted to purify it on silica or alumina adsorbents (ESI, † S12). Therefore, the analysis and purification of [ 1 and 2) . Increasing the amount of 2 (entry 3) or increasing the concentration of the reactants (by reducing the amount of solvent, entry 4) did not change significantly the RCC (42% and 37% respectively). Contrarily, decreasing the concentration (entry 5) led to increasing of RCC (56%), albeit an elongated time for the evaporation of DCM (entry 5). Therefore, we kept the solvent volume at 500 mL in the subsequent experiments. It was found that the RCC was nearly unchanged when the reaction was carried out at room temperature instead of 70 1C (entry 6). Moreover, the reaction time could be shortened to five minutes without decreasing the RCC (41%, entry 7) thus reducing significantly the duration of the radiosynthesis of [
18 F]1.
In the above procedures (entries 1-7), we employed 70 1C for the extraction of the solid residue that remained after the evaporation of DCM. Decreasing the extraction temperature to 40 1C or room temperature (entries 8 and 9) led to significant decrease of the RCC (20-23%). The optimal procedure (entry 7) involves the reaction of 2 and [ 18 F]TBAF in 500 mL DCM (5 minutes at room temperature); then evaporation of DCM and extraction of the solid residue by hexane for one minute at 70 1C.
As mentioned above, the fluorine-19 experiments showed that TBAF is insoluble in hexane. To confirm this observation, we made a further control experiment using [ reactions of o-styrilamides 3. Gulder and co-workers 12b,k have shown that using equimolar amounts of 3 and 1 a rapid fluorocyclization can be performed at room temperature resulting in fluorobenzoxazepines bearing a quaternary fluoride. a 2 (12 mmol) and [ 18 F]Bu 4 NF were mixed in DCM (500 mL) and stirred at the indicated temperature and time. The solvent was removed under a N 2 stream. To the obtained solid residue was added hexane (500 mL) and stirred for 1 minute at the given temperatures (Extr. temp.). The extracted activity indicates the percentage of total activity extracted in the hexane phase as average of two experiments (n = 2).
b 250 mL of DCM instead of 500 mL. c 1000 mL of DCM instead of 500 mL. DCM = dichloromethane.
Radiosynthesis of [ 18 F]4 was performed by adding the hexane solution of [
18 F]1 to a solution of precursor 3 in acetonitrile followed by evaporation of the solvents. Subsequently, the solid residue was dissolved in acetonitrile (500 mL) and the fluorocyclization reaction was studied at different temperatures and reaction times ( We also performed one-pot reactions without isolation and purification of [ 18 F]1 (Fig. 2) . When the one-pot reaction was performed in two sequential steps: (1) 
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